Patents by Inventor Suni Mustafa

Suni Mustafa has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PYRIMIDINE NON-CLASSICAL CANNABINOID COMPOUNDS AND RELATED METHODS OF USE
    Publication number: 20100069634
    Abstract: Disclosed are compounds of the formula I: wherein R1, R2, V, W, X, Y and Z can be as defined herein. The compounds can be used in the treatment of disorders mediated by the cannabinoid receptors.
    Type: Application
    Filed: October 14, 2009
    Publication date: March 18, 2010
    Inventors: Bob M. Moore, II, Steven Gurley, Suni Mustafa, Patrick Allison
  • PYRIDINE NON-CLASSICAL CANNABINOID COMPOUNDS AND RELATED METHODS OF USE
    Publication number: 20100069440
    Abstract: Disclosed are compounds of the formula I: wherein R1, R2, V, W, X, Y and Z can be as defined herein. The compounds can be used in the treatment of disorders mediated by the cannabinoid receptors.
    Type: Application
    Filed: October 14, 2009
    Publication date: March 18, 2010
    Inventors: Bob M. Moore, II, Steven Gurley, Suni Mustafa
  • Pyridine Non-Classical Cannabinoid Compounds and Related Methods of Use
    Publication number: 20090286818
    Abstract: wherein R1, R2, V, W, X, Y and Z can be as defined herein. The compounds can be used in the treatment of disorders mediated by the cannabinoid receptors.
    Type: Application
    Filed: May 19, 2009
    Publication date: November 19, 2009
    Inventors: Bob M. Moore, II, Steven Gurley, Suni Mustafa
  • Pyrimidine Classical Cannabinoid Compounds and Related Methods of Use
    Publication number: 20090286815
    Abstract: Disclosed are compounds of the formula I: wherein R1, R2, V, W, X, Y and Z can be as defined herein. The compounds can be used in the treatment of disorders mediated by the cannabinoid receptors.
    Type: Application
    Filed: May 19, 2009
    Publication date: November 19, 2009
    Inventors: Bob M. Moore, II, Steven Gurley, Suni Mustafa, Patrick Allison
  • Pyridine Classical Cannabinoid Compounds and Related Methods of Use
    Publication number: 20090286824
    Abstract: Disclosed are compounds of the formula I: wherein R1, R2, V, W, X, Y and Z can be as defined herein. The compounds can be used in the treatment of disorders mediated by the cannabinoid receptors.
    Type: Application
    Filed: May 19, 2009
    Publication date: November 19, 2009
    Inventors: Bob M. Moore, II, Steven Gurley, Suni Mustafa
  • Pyrimidine Non-Classical Cannabinoid Compounds and Related Methods of Use
    Publication number: 20090286810
    Abstract: Disclosed are compounds of the formula I: wherein R1, R2, V, W, X, Y and Z can be as defined herein. The compounds can be used in the treatment of disorders mediated by the cannabinoid receptors.
    Type: Application
    Filed: May 19, 2009
    Publication date: November 19, 2009
    Inventors: Bob M. Moore, II, Steven Gurley, Suni Mustafa, Patrick Allison
  • Yohimbine derivatives and use thereof
    Patent number: 7470703
    Abstract: Yohimbine derivatives are disclosed having modification of the C-16 carboxyl group to include a sidechain and where the resulting derivative does not possess a second yohimbine pharmacophore (i.e., the compound is not a yohimbine dimer). The yohimbine derivatives of the present invention are preferably characterized by selective activity as ?2c-AR antagonists. Use of the compounds, or pharmaceutical composition containing them, for treating or preventing an ?2c adrenergic receptor mediated condition or disorder, and for antagonizing activity of an ?2c adrenergic receptor are also disclosed.
    Type: Grant
    Filed: August 23, 2005
    Date of Patent: December 30, 2008
    Assignees: The University of Tennessee Research Foundation, The University of Mississippi
    Inventors: Duane D. Miller, Bob M. Moore, II, Suni Mustafa, Dennis R. Feller, Supriya A. Bavadekar
  • Yohimbine dimers exhibiting binding selectivities for alpha2 adrenergic receptors
    Publication number: 20040157871
    Abstract: The present invention relates to yohimbine dimer compounds, pharmaceutical compositions containing such dimer compounds, methods of making such dimer compounds, and uses thereof.
    Type: Application
    Filed: October 6, 2003
    Publication date: August 12, 2004
    Inventors: Duane D. Miller, Weiping Zheng, Bob M. Moore, Suni Mustafa, Dennis Rudolph Feller, Longping Lei, Shilpa G. Lalchandani
  • Yohimbine dimers exhibiting binding selectivities for &agr;2 adrenergic receptors
    Patent number: 6638943
    Abstract: The present invention relates to yohimbine dimer compounds, pharmaceutical compositions containing such dimer compounds, methods of making such dimer compounds, and uses thereof. The yohimbine dimer compounds include compounds of formula (I): where R is any linker molecule which affords a yohimbine dimer that has activity as an &agr;2-AR antagonist and has selectivity for an &agr;2-AR subtype over another &agr;2-AR subtype.
    Type: Grant
    Filed: March 25, 2002
    Date of Patent: October 28, 2003
    Assignee: The University of Tennessee Research Foundation
    Inventors: Duane D. Miller, Weiping Zheng, Bob M. Moore, II, Suni Mustafa
  • Yohimbine dimers exhibiting binding selectivities for alpha2 adrenergic receptors
    Publication number: 20030036547
    Abstract: The present invention relates to yohimbine dimer compounds, pharmaceutical compositions containing such dimer compounds, methods of making such dimer compounds, and uses thereof.
    Type: Application
    Filed: March 25, 2002
    Publication date: February 20, 2003
    Inventors: Duane D. Miller, Weiping Zheng, Bob M. Moore, Suni Mustafa